MYL1, MYL2, MYH2, and MYH7 expression levels were significantly down-regulated in stage II, III, IV compared with stage I, MYL1 is a potential special poor prognostic marker in HNSCC. Here, MYL1 is linked to head and neck squamous cell carcinoma.